Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irina Y Sazonova

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|June 25, 2002
Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasminRyan B Turner, Lin Liu, Irina Y Sazonova, et al.
Biochemistry|July 10, 2007
Regulation of nonproteolytic active site formation in plasminogenInna P Gladysheva, Irina Y Sazonova, Aiilyan Houng, et al.
Methods in Enzymology|March 28, 2012
Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticlesS Sibel Erdem, Irina Y Sazonova, Tetsuya Hara, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2003
Coevolutionary patterns in plasminogen activationInna P Gladysheva, Ryan B Turner, Irina Y Sazonova, et al.
The Journal of Biological Chemistry|April 8, 2004
alpha Domain deletion converts streptokinase into a fibrin-dependent plasminogen activator through mechanisms akin to staphylokinase and tissue plasminogen activatorIrina Y Sazonova, Brian R Robinson, Inna P Gladysheva, et al.
The Journal of Biological Chemistry|May 23, 2002
Chimerism reveals a role for the streptokinase Beta -domain in nonproteolytic active site formation, substrate, and inhibitor interactionsInna P Gladysheva, Irina Y Sazonova, Shakeel A Chowdhry, et al.
Journal of Investigative Medicine High Impact Case Reports|October 2, 2015
Embolic Stroke Diagnosed by Elevated D-Dimer in a Patient With Negative TEE for Cardioembolic SourceIrina Y Sazonova, Roja Pondicherry-Harish, Nikhil Kadle, et al.
Experimental & Translational Stroke Medicine|December 20, 2011
Sex-independent neuroprotection with minocycline after experimental thromboembolic strokeMd Nasrul Hoda, Weiguo Li, Ajmal Ahmad, et al.
Stroke|July 25, 2009
Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potentialLivia S Machado, Irina Y Sazonova, Anna Kozak, et al.
Nanomedicine (London, England)|February 22, 2012
Multifunctional nanoagent for thrombus-targeted fibrinolytic therapyJason R McCarthy, Irina Y Sazonova, S Sibel Erdem, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|June 25, 2002
Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasminRyan B Turner, Lin Liu, Irina Y Sazonova, et al.
Biochemistry|July 10, 2007
Regulation of nonproteolytic active site formation in plasminogenInna P Gladysheva, Irina Y Sazonova, Aiilyan Houng, et al.
Methods in Enzymology|March 28, 2012
Detection and treatment of intravascular thrombi with magnetofluorescent nanoparticlesS Sibel Erdem, Irina Y Sazonova, Tetsuya Hara, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2003
Coevolutionary patterns in plasminogen activationInna P Gladysheva, Ryan B Turner, Irina Y Sazonova, et al.
The Journal of Biological Chemistry|April 8, 2004
alpha Domain deletion converts streptokinase into a fibrin-dependent plasminogen activator through mechanisms akin to staphylokinase and tissue plasminogen activatorIrina Y Sazonova, Brian R Robinson, Inna P Gladysheva, et al.
The Journal of Biological Chemistry|May 23, 2002
Chimerism reveals a role for the streptokinase Beta -domain in nonproteolytic active site formation, substrate, and inhibitor interactionsInna P Gladysheva, Irina Y Sazonova, Shakeel A Chowdhry, et al.
Journal of Investigative Medicine High Impact Case Reports|October 2, 2015
Embolic Stroke Diagnosed by Elevated D-Dimer in a Patient With Negative TEE for Cardioembolic SourceIrina Y Sazonova, Roja Pondicherry-Harish, Nikhil Kadle, et al.
Experimental & Translational Stroke Medicine|December 20, 2011
Sex-independent neuroprotection with minocycline after experimental thromboembolic strokeMd Nasrul Hoda, Weiguo Li, Ajmal Ahmad, et al.
Stroke|July 25, 2009
Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potentialLivia S Machado, Irina Y Sazonova, Anna Kozak, et al.
Nanomedicine (London, England)|February 22, 2012
Multifunctional nanoagent for thrombus-targeted fibrinolytic therapyJason R McCarthy, Irina Y Sazonova, S Sibel Erdem, et al.
Pageof 2